RSS
20 May 2020

Kindred Biosciences Announces COVID-19 Vaccine Manufacturing Agreement with Vaxart

Author: admintech | Filed under: Press Release

SAN FRANCISCO, May 20, 2020 /PRNewswire/ — Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company developing novel biologics, today announced it has entered into an agreement with Vaxart, Inc. (Nasdaq: VXRT) for the manufacture of Vaxart’s oral vaccine candidate for…

This entry was posted on Wednesday, May 20th, 2020 at 7:10 am and is filed under Press Release. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.

«

»